Cell repair/replacing strategies for neurodegenerative diseases such as Parkinson's disease
depend on well-characterized dopaminergic neuronal candidates that are healthy and show …

Blood‐brain barrier (BBB) is a term describing the highly selective barrier formed by the
endothelial cells (ECs) of the central nervous system (CNS) homeostasis by restricting …

To understand the process of neurogenesis, generation of functional dopaminergic
(DAergic) neurons from human mesenchymal stem cells (hMSCs) is important. BDNF has …

Mesenchymal stem cells (MSCs) showed the potential to treat Parkinson's disease (PD).
However, it is unknown whether the conditioned medium of human menstrual blood-derived …

Mesenchymal stromal cells (MSCs) exhibit beneficial anti-inflammatory effects against
Parkinson's disease (PD) via immunomodulatory actions. However, the underlying …

Systemic immunomodulation is increasingly recognized among the beneficial effects of
mesenchymal stromal cells (MSCs) in treatment of Parkinson's disease (PD), while the …

Parkinson's disease (PD) is characterized by loss of dopaminergic neurons, oxidative stress
and neuroinflammation. The classical therapeutic approach with L-DOPA is not able to …

Parkinson's disease (PD) is a neurodegenerative condition characterized by the progressive
and selective loss of dopaminergic (DAergic) neurons in the midbrain. The replacement of …

Oxysterols play vital roles in the human body, ranging from cell cycle regulation and
progression to dopaminergic neurogenesis. While naïve human mesenchymal stem cells …

With no permanent cure for neurodegenerative diseases, the symptoms reappear shortly
after the withdrawal of medicines. A better treatment outcome can be expected if the …